ANI Pharma Insider Sells 4,772 Shares as Revenue Hits $883 Million in 2025
Thomas Rowland, an executive at ANI Pharmaceuticals (NASDAQ:ANIP), reported the sale of 4,772 shares of common stock in an open-market…
Thomas Rowland, an executive at ANI Pharmaceuticals (NASDAQ:ANIP), reported the sale of 4,772 shares of common stock in an open-market…
Elon Musk’s latest obsession and the project he is super focused on is reportedly Ani, an artificial intelligence girlfriend created…